Current treatment status and medical costs for hemodialysis vascular access based on analysis of the Korean Health Insurance Database.

ABSTRACT:

Background/aims

The Republic of Korea is a country where the hemodialysis population is growing rapidly. It is believed that the numbers of treatments related to vascular access-related complications are also increasing. This study investigated the current status of treatment and medical expenses for vascular access in Korean patients on hemodialysis.

Methods

This was a descriptive observational study. We inspected the insurance claims of patients with chronic kidney disease who underwent hemodialysis between January 2008 and December 2016. We calculated descriptive statistics of the frequencies and medical expenses of procedures for vascular access.

Results

The national medical expenses for access-related treatment were 7.12 billion KRW (equivalent to 6.36 million US

SUBMITTER: Lee HS 

PROVIDER: S-EPMC6234403 | biostudies-literature | 2018 Nov

REPOSITORIES: biostudies-literature